Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOSH-101 topical in male androgenetic alopecia
2005-003901-10Phase 2Completed
- Sponsor
- Neosil
- Start
- Feb 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in androgenetic alopecia (AGA) comparing NEOSH-101 topical with Vehicle placebo topical (2 arms). Primary endpoint: Change in hair density. Started Feb 2007; status: completed.
02
Drugs
neosh101
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2005-003901-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003901-10.